NCT04114448

Brief Summary

Objectives: To assess the efficacy of performing a therapeutic exercise program, compared with usual care, on pain relief, range of movement and self-perceived quality of life in patients with hemophilia Design: Quantitative, experimental, longitudinal and prospective study. Subjects: Male patients between 30 and 45 years old, with hemophilia type A or B and with knee, ankle or elbow arthropathy caused by hemophilia. Participants may be undergoing a pharmacologic treatment with intravenous VIII and/or IX factor Methods: Participants in the experimental group will an intervention based on therapeutic exercise. One therapist will instruct the patients during two sessions (each lasting approximately 1 hour). Participants will be asked to continue this program at least twice a week. Meanwhile, those in the control group will receive usual physical therapy care, based on a more passive approach, including self-assisted joint mobilization and muscle stretching. Those in the control group will be also instructed to perform the protocol at home, at least twice a week. The intervention protocol in both groups will last three months

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 3, 2019

Completed
1.5 years until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2022

Enrollment Period

2 years

First QC Date

September 27, 2019

Last Update Submit

May 8, 2023

Conditions

Keywords

HemophiliaTherapeutic exercisePhysical therapyRandomized controlled trialPain perceptionRange of movement

Outcome Measures

Primary Outcomes (6)

  • Pressure pain threshold (PPT) in the evaluated muscles.

    The PPT levels will be evaluated in KPa. PPT levels, defined as the minimum necessary pressure to evoke pain will be evaluated using a handheld electronic pressure algometer.

    Change from baseline to 3 months after intervention

  • Self-reported pain intensity: Numeric Pain Rating Scale (NPRS)

    Self-reported pain will be evaluated using the Numeric Pain Rating Scale (NPRS), where 0 denotes no pain at all, and 10 denotes the maximum possible pain.

    Change from baseline to 3 months after intervention

  • Range of movement (ROM).

    Active ROM of the affected joint will be evaluated using inertial sensors, that measure lineal acceleration and angular velocity.

    Change from baseline to 3 months after intervention

  • General flexibility

    General flexibility will be assessed using the improved tot-flex test, which makes possible to extrapolate general flexibility from a combined movement measure.

    Change from baseline to 3 months after intervention

  • Daily life activities

    Ordinary daily life activities will be assessed using the Haemophilia Activities List, which measures the self-perceived functional state.

    Change from baseline to 3 months after intervention

  • Self-perceived quality of life: A36 Haemophilia-QoL test

    Quality of life will be evaluated using the A36 Haemophilia-QoL test. This is a valid and specific tool for hemophiliac adults.

    Change from baseline to 3 months after intervention

Study Arms (2)

Therapeutic exercise

EXPERIMENTAL

Patients will be trained to perform a therapeutic exercise intervention protocol. The program will be based on active physical activity including strength, balance an coordination exercises, among others. Each initial contact session will last approximately 1 hour. After baseline, participants will be instructed to undergo at least two sessions per week during 3 consecutive months.

Other: Therapeutic exercise

Usual care

ACTIVE COMPARATOR

Patients will be instructed to perform an usual care physical therapy intervention protocol. Participants in this group will be told to undergo gentle self-performed joint mobilization and stretching exercises. Each initial contact session will last approximately 1 hour. After baseline, participants will be instructed to undergo at least two sessions per week during 3 consecutive months.

Other: Usual physical therapy care

Interventions

Patients will perform an exercise protocol specifically designed for patients with hemophilia that will include exercises focused on improving range of movement, strength, flexibility, balance and coordination as well as diaphragmatic breathing at the start and at the beginning of each session.

Therapeutic exercise

Patients will undergo usual physical therapy treatment for hemophiliacs, based on affected self and gentle joint mobilization and stretching of muscles involved in the affected joints.

Usual care

Eligibility Criteria

Age30 Years - 45 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of hemophilia type A or hemophilia type B.
  • Knee, elbow or ankle arthropathy caused by hemophilia
  • Pharmacological treatment based on using VIII or IX factor concentrates.

You may not qualify if:

  • Presence of VIII FIX inhibitors.
  • Having received anti-inflammatory treatment using Arcoxia (Etoricoxib)
  • Having undergone a surgical intervention at the target joint.
  • Patients enrolled in other research which implies doing physical exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sevilla

Seville, 41009, Spain

Location

MeSH Terms

Conditions

Hemophilia A

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Alberto M Heredia-Rizo, PhD

    Physiotherapy Department, University of Sevilla, Spain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor. Physiotherapy Department

Study Record Dates

First Submitted

September 27, 2019

First Posted

October 3, 2019

Study Start

April 1, 2021

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

May 10, 2023

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations